The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics — Alan Cass (2021) | RDL Network
The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics
Article 2021 en
Authors
AC
Alan Cass
JF
John Feehally
JF
Jürgen Floege
Abstract
1 min read
The TESTING study (combined full and low dose) will define the benefits of corticosteroid use on major kidney outcomes, as well as the risks of therapy, and provide data on the relative effects of different doses, in individuals with high-risk IgAN.
Wong M.G., Jun Lv, Hladunewich M.A., Jha V., Hooi L.S., Helen Monaghan, Mingfang Zhao, Sean Barbour, R. N., Daniel Cattran, Richard J. Glassock, Anna Levin, Jardine M.J., Wheeler D.C., Mark Woodward, Laurent Billot, Chan T.M., Hongbo Liu, Johnson D.W., Alan Cass, J. Feehally, Jürgen Floege, Giuseppe Remuzzi, Yi‐Long Wu, Rajiv Agarwal, Hengguo Zhang, Vlado Perkovic, for the TESTING Study Group
Jin‐Soon Suh, Kyung Mi Jang, Hyesun Hyun, Myung Hyun Cho, Joo Hoon Lee, Young Seo Park, Jae Hyuk Oh, Ji Hong Kim, Kee Hwan Yoo, Woo Yeong Chung, Seong Heon Kim, Kim Kee-Hyuck, Dae Yeol Lee, Jung Won Lee, Min Hyun Cho, Hyewon Park, Ja Wook Koo, Kyoung Hee Han, Eun Mi Yang, Keum Hwa Lee, Jae Il Shin, Heeyeon Cho, Kyo Soon Kim, ,
William G. Herrington, Christoph Wanner, Parminder K. Judge, Kaitlin J. Mayne, Doreen Zhu, Natalie Staplin, David Preiss, Will Stevens, Karl Wallendszus, Carol Knott, Michael D. Hill, Jonathan Emberson, Vladimir Cejka, Alfred K. Cheung, Jing Li, Lai Seong Hooi, Wen Liu, Masaomi Nangaku, Adeera Levin, David Z.I. Cherney, Roberto Pontremoli, Aldo Maggioni, Shinya Goto, Aiko Tomita, ,
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.